Cargando…
One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India—TRUST (Tresiba real-world use study)
OBJECTIVE: This post-authorization safety study (PASS) was conducted to evaluate the long-term safety and effectiveness of insulin degludec in patients with diabetes mellitus (DM) requiring insulin therapy in routine clinical practice in India. METHODS: Data on glycated hemoglobin (HbA1c) and advers...
Autores principales: | Kesavadev, Jothydev, Murthy, L.Sreenivasa, Chaudhury, Tirthankar, Yalamanchi, Sadasiva Rao, Giri, J., Gupta, Sunil, Phatak, Sanjeev, Modi, K.D., Chatterjee, Sanjay, Manjunath, Aparna, Revanna, Manjunatha, Bhattacharya, Arpandev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046940/ https://www.ncbi.nlm.nih.gov/pubmed/35496980 http://dx.doi.org/10.1016/j.metop.2022.100184 |
Ejemplares similares
-
Safety of Insulin Degludec/Insulin Aspart in Patients with Diabetes Mellitus over a Period of 1 Year during Routine Clinical Care in India: SMART (Study of Management of Diabetes with Ryzodeg™ Treatment)
por: Kesavadev, Jothydev, et al.
Publicado: (2021) -
Evaluation of Tresiba Combined with Six Ingredient Rehmannia Pill in the Treatment of Type 2 Diabetes
por: Li, Jun, et al.
Publicado: (2022) -
Retracted: Evaluation of Tresiba Combined with Six Ingredient Rehmannia Pill in the Treatment of Type 2 Diabetes
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market
por: Murthy, Sreenivasa, et al.
Publicado: (2021) -
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Trivandrum cohort of the A(1)chieve study
por: Kesavadev, Jothydev
Publicado: (2013)